FYLNETRA

Manufacturer:

Amneal

Name:

FYLNETRA

HCPCS Code Descriptor:

Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg

Category:

Q Code

HCPCS:

Q5130

NDC(s):

70121-1627-01

Primary Type:

Oncology Biosimilar Colony Stimulating Factor

Generic/Specialty Status:

NEULASTA Biosimilar

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

70121-1627-01

About:

FYLNETRA is an Oncology Biosimilar Colony Stimulating Factor drug manufactured by Amneal and administered via the Subcutaneous route of administration. The Q Code: Q5130 is aligned to the drug FYLNETRA.

Fylnetra (pegfilgrastim) is a protein that aids the production of white blood cells (neutrophils) and is used to help prevent the lack of neutrophils in a patient. Fylnetra is produced by Amneal Pharmaceuticals and is biosimilar to the medication Neulasta (J2506). This drug was assigned the HCPCS code Q5130 in April 2023. Patient assistance programs for Flynetra can be found through the Amneal Patient Assistance Program.